Analyst Gil Blum Reaffirms Confidence in Autolus Therapeutics with Buy Rating and Unchanged Price Target
December 2, 2023: In a recent evaluation, Gil Blum, the esteemed Needham analyst, has once again expressed his unwavering confidence ...
December 2, 2023: In a recent evaluation, Gil Blum, the esteemed Needham analyst, has once again expressed his unwavering confidence ...
Autolus Therapeutics plc (NASDAQ:AUTL) experienced a significant decrease in short interest during the month of August, according to the latest ...
In its most recent Form 13F filing with the Securities and Exchange Commission (SEC), ProShare Advisors LLC has reported an ...
Public Sector Pension Investment Board has significantly increased its stake in The Beauty Health Company during the first quarter of ...
ExodusPoint Capital Management LP has recently increased its stake in Autolus Therapeutics plc, a clinical-stage biopharmaceutical company specializing in the ...
On September 5, 2023, Autolus Therapeutics made an exciting announcement regarding the publication of data from the AUTO1/22 Phase 1 ...
Autolus Therapeutics plc (NASDAQ:AUTL) experienced a significant decline in short interest during the month of August, according to recent data. ...
August 22, 2023 - MAI Capital Management, a renowned institutional investor, has recently reported a reduction in its stake in ...
Autolus Therapeutics plc (NASDAQ:AUTL) experienced a 3.1% increase in its share price during mid-day trading on Friday, following Truist Financial's ...
Autolus Therapeutics' groundbreaking therapy, Obe-Cel, is revolutionizing the field of CD19 CAR T cell treatments. Unlike its predecessors, Obe-Cel addresses ...
DISCLAIMER
Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.
The Best Stocks, its managers, its employees, affiliates and assigns (collectively “The Company”) do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.
Categories
Best Stocks to buy now
Crypto
Dow Jones Today
Pre-IPO and Startups
Tech stocks
Utility Stocks
Data and Tools
Stock Forecast
Dow Jones Today
© 2023 Best Stocks